Pyrroloquinoline quinone is a potent neuroprotective nutrient against 6-hydroxydopamine-induced neurotoxicity

Neurochemical Research

Volumn 32, Issue 3, 2007, Pages 489-495

  Hara, Hirokazu ^a   Hiramatsu, Hideaki ^a   Adachi, Tetsuo ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

6 Hydroxydopamine; Antioxidant; Neuroprotection; Oxidative stress; Pyrroloquinoline quinone

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; DNA FRAGMENT; HYDROETHIDINE; OXIDOPAMINE; PYRROLOQUINOLINEQUINONE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; VITAMIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL;

ALPHA-TOCOPHEROL; ASCORBIC ACID; CELL LINE, TUMOR; CELL SURVIVAL; FLOW CYTOMETRY; FREE RADICAL SCAVENGERS; HUMANS; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDOPAMINE; PQQ COFACTOR; SUPEROXIDES;

EID: 33847129668     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-006-9257-x     Document Type: Article

References (40)

1. Gallop PM, Paz MA, Fluckiger R, et al (1989) PQQ, the elusive coenzyme. Trends Biochem Sci 14:343-346
2. Goodwin PM, Anthony C (1998) The biochemistry, physiology and genetics of PQQ and PQQ-containing enzymes. Adv Microb Physiol 40:1-80
3. Kumazawa T, Seno H, Urakami T, et al (1992) Trace levels of pyrroloquinoline quinone in human and rat samples detected by gas chromatography/mass spectrometry. Biochim Biophys Acta 1156:62-66
4. Killgore J, Smidt C, Duich L, et al (1989) Nutritional importance of pyrroloquinoline quinone. Science 245:850-852
5. Steinberg FM, Gershwin ME, Rucker RB (1994) Dietary pyrroloquinoline quinone: growth and immune response in BALB/c mice. J Nutr 124:744-753
6. Zhang Y, Rosenberg PA (2002) The essential nutrient pyrroloquinoline quinone may act as a neuroprotectant by suppressing peroxynitrite formation. Eur J Neurosci 16:1015-1024
7. Zhu BQ, Simonis U, Cecchini G, et al (2006) Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury. J Cardiovasc Pharmacol Ther 11:119-128
8. Nishigori H, Yasunaga M, Mizumura M, et al (1989) Preventive effects of pyrroloquinoline quinone on formation of cataract and decline of lenticular and hepatic glutathione of developing chick embryo after glucocorticoid treatment. Life Sci 45:593-598
9. Jenner P (2003) Oxidative stress in Parkinson's disease. Ann Neurol 53:S26-S38
10. Sian J, Dexter DT, Lees AJ, et al (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348-355
11. Cohen G, Heikkila RE (1974) The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem 249:2447-2452
12. Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14:633-643
13. Hastings TG (1995) Enzymatic oxidation of dopamine: the role of prostaglandin H synthase. J Neurochem 64:919-924
14. Bensadoun JC, Mirochnitchenko O, Inouye M, et al (1998) Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. Eur J Neurosci 10:3231-3236
15. Andrew R, Watson DG, Best SA, et al (1993) The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res 18:1175-1177
16. Glinka Y, Gassen M, Youdim MB (1997) Mechanism of 6-hydroxydopamine neurotoxicity. J Neural Transm Suppl 50:55-66
17. 2 and 6-hydroxydopamine. Mov Disord 13:242-248
18. Soto-Otero R, Mendez-Alvarez E, Hermida-Ameijeiras A, et al (2000) Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: potential implication in relation to the pathogenesis of Parkinson's disease. J Neurochem 74:1605-1612
19. Hara H, Ohta M, Ohta K, et al (2003) Apomorphine attenuates 6-hydroxydopamine-induced apoptotic cell death in SH-SY5Y cells. Redox Rep 8:193-197
20. Hara H, Ohta M, Ohta K, et al (2003) Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res 119:125-131
21. Munoz FJ, Opazo C, Gil-Gomez G, et al (2002) Vitamin E but not 17beta-estradiol protects against vascular toxicity induced by beta-amyloid wild type and the Dutch amyloid variant. J Neurosci 22:3081-3089
22. Asanuma M, Hirata H, Cadet JL (1998) Attenuation of 6-hydroxydopamine- induced dopaminergic nigrostriatal lesions in superoxide dismutase transgenic mice. Neuroscience 85:907-917
23. +-induced dopaminergic neuronal cell death: role of caspases, ROS, and JNK. J Neurosci Res 57:86-94
24. Barkats M, Millecamps S, Bilang-Bleuel A, et al (2002) Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine. J Neurochem 82:101-109
25. Callio J, Oury TD, Chu CT (2005) Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains. J Biol Chem 280:18536-18542
26. He K, Nukada H, Urakami T, et al (2003) Antioxidant and pro-oxidant properties of pyrroloquinoline quinone (PQQ): implications for its function in biological systems. Biochem Pharmacol 65:67-74
27. Jensen FE, Gardner GJ, Williams AP, et al (1994) The putative essential nutrient pyrroloquinoline quinone is neuroprotective in a rodent model of hypoxic/ischemic brain injury. Neuroscience 62:399-406
28. Zhang Y, Feustel PJ, Kimelberg HK (2006) Neuroprotection by pyrroloquinoline quinone (PQQ) in reversible middle cerebral artery occlusion in the adult rat. Brain Res 1094:200-206
29. Otero P, Viana M, Herrera E, et al (1997) Antioxidant and prooxidant effects of ascorbic acid, dehydroascorbic acid and flavonoids on LDL submitted to different degrees of oxidation. Free Radic Res 27:619-626
30. Choi HY, Song JH, Park DK, et al (2000) The effects of ascorbic acid on dopamine-induced death of PC12 cells are dependent on exposure kinetics. Neurosci Lett 296:81-84
31. Heikkila RE, Cohen G (1973) 6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediate. Science 181:456-457
32. Hamagishi Y, Murata S, Kamei H, et al (1990) New biological properties of pyrroloquinoline quinone and its related compounds: inhibition of chemiluminescence, lipid peroxidation and rat paw edema. J Pharmacol Exp Ther 255:980-985
33. Misra HS, Khairnar NP, Barik A, et al (2004) Pyrroloquinoline-quinone: a reactive oxygen species scavenger in bacteria. FEBS Lett 578:26-30
34. Urakami T, Yoshida C, Akaike T, et al (1997) Synthesis of monoesters of pyrroloquinoline quinone and imidazopyrroloquinoline, and radical scavenging activities using electron spin resonance in vitro and pharmacological activity in vivo. J Nutr Sci Vitaminol (Tokyo) 43:19-33
35. Hara H, Ohta M, Adachi T (2006) Apomorphine protects against 6-hydroxydopamine-induced neuronal cell death through activation of the Nrf2-ARE pathway. J Neurosci Res 84:860-866
36. Yamaguchi K, Sasano A, Urakami T, et al (1993) Stimulation of nerve growth factor production by pyrroloquinoline quinone and its derivatives in vitro and in vivo. Biosci Biotechnol Biochem 57:1231-1233
37. Murase K, Hattori A, Kohno M, et al (1993) Stimulation of nerve growth factor synthesis/secretion in mouse astroglial cells by coenzymes. Biochem Mol Biol Int 30:615-621
38. Aizenman E, Hartnett KA, Zhong C, et al (1992) Interaction of the putative essential nutrient pyrroloquinoline quinone with the N-methyl-D-aspartate receptor redox modulatory site. J Neurosci 12:2362-2369
39. Naarala J, Nykvist P, Tuomala M, et al (1993) Excitatory amino acid-induced slow biphasic responses of free intracellular calcium in human neuroblastoma cells. FEBS Lett 330:222-226
40. - cotransporter in neuronal cells by excitatory neurotransmitter glutamate. Am J Physiol 275:C772-C779